Hearing Loss Prevention (HLP)
O'neil Guthrie, PhD
Associate Professor
Northern Arizona University
Flagstaff, Arizona, United States
The current research reveals that auditory function can be protected by exploiting and potentiating genes that defend genomic DNA.
Summary:
Rationale/
Purpose: Bacteria can effectively avoid cell death by activating pro-survival DNA repair genes. If the mammalian cochlea had a similar defensive response that could be therapeutically optimized, then it might be possible to exploit this mechanism in order to limit the progression of permanent hearing loss.
Design: Pigmented rats served as subjects. They were randomized into the following groups: control, noise-exposure, treatment, and noise+treatment. The noise exposure consisted of a hazardous noise dose (105 dB/16 hrs). Cyanoethyl phosphoramidite chemistry was used to engineer a molecular construct that was used on the treatment groups.
Results: The engineered construct was shown to be particularly effective at activating pro-survival DNA repair genes within the mammalian cochlea. This activation was characterized by a statistically significant (p < 0.05) increase in a panel of DNA repair genes. The experiment further revealed that mobilization of this response can limit disease progression in the form of statistically significant (p < 0.05) reduction of sensorineural hearing loss.
Conclusion: The data reveals that the particular therapeutic approach used in the current experiment could be developed as novel medicinal therapy to prevent or treat hearing loss.